AERI - Aerie Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.08B
Enterprise Value 3974.7M
Trailing P/E N/A
Forward P/E 1-23.42
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)22.21
Price/Book (mrq)6.91
Enterprise Value/Revenue 320.12
Enterprise Value/EBITDA 6-4.89

Trading Information

Stock Price History

Beta (3Y Monthly) 0.42
52-Week Change 3-62.57%
S&P500 52-Week Change 32.33%
52 Week High 364.45
52 Week Low 320.72
50-Day Moving Average 323.78
200-Day Moving Average 336.61

Share Statistics

Avg Vol (3 month) 3810.91k
Avg Vol (10 day) 31.04M
Shares Outstanding 545.92M
Float 38.78M
% Held by Insiders 11.84%
% Held by Institutions 1112.53%
Shares Short (Jul 31, 2019) 46.92M
Short Ratio (Jul 31, 2019) 47.87
Short % of Float (Jul 31, 2019) 417.79%
Short % of Shares Outstanding (Jul 31, 2019) 415.07%
Shares Short (prior month Jun 28, 2019) 45.42M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-428.30%

Management Effectiveness

Return on Assets (ttm)-44.18%
Return on Equity (ttm)-132.31%

Income Statement

Revenue (ttm)48.45M
Revenue Per Share (ttm)1.08
Quarterly Revenue Growth (yoy)553.50%
Gross Profit (ttm)-3M
EBITDA -199.22M
Net Income Avi to Common (ttm)-231.96M
Diluted EPS (ttm)-5.17
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)109.36M
Total Cash Per Share (mrq)2.38
Total Debt (mrq)18.73M
Total Debt/Equity (mrq)12.03
Current Ratio (mrq)2.52
Book Value Per Share (mrq)3.39

Cash Flow Statement

Operating Cash Flow (ttm)-159.89M
Levered Free Cash Flow (ttm)-103.2M